1.Conigrave K, Davies P, Haber P, Whitfield J. Traditional markers of excessive alcohol use. Addiction. 2003;98:31-43. 2.Bjerre B, Borg S, Helander A, Jeppson JO, Johnson G, Karlsson K. CDT värdefull markör för överkonsumtion av alkohol. Riktlinjer för dess användning vid körkortsprövning. Läkartidningen. 2001;98:677-83. 3.Varga A, Hansson P, Lundqvist C, Alling C. Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: Comparison with other markers. Acohol Clin Exp Res. 1998;22:1832-7. 4.Varga A, Hansson P, Johnson G, Alling C. Normalization rate and cellular localization of phos-phatidylethanol in whole blood from chronic alcoholics. Clinica Chemica Acta. 2000;299:141-50. 5.Aradottir S, Asanovska G, Gjerss S, Hansson P, Alling C. Phosphati-dylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-depend-ent patients. Alcohol Alcohol. 2006;41:431-7. 6.Hartmann S, Aradottir S, Graf M, Wiesbeck G, Lesch O, Ramskogler K, et al. Phosphatidylethanol as a sensitive and specific biomarker-comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin. Addict Biol. 2006;12:81-4. 7.Varga A. Phosphatidylethanol in blood as a marker of alcohol abuse [dissertation]. Lund: Lunds universitet; 2001. 8.Aradóttir S. Phosphatidylethanol-formation and degradation in blood and organs [dissertation]. Lund: Lunds universitet; 2004. 9.Läkemedelsboken 2005–2006. Stockholm: Apoteket AB;2005; p. 837.10.Andréasson S, Allebeck P, redaktörer. En kunskapsöversikt om alkoholens positiva och negativa effekter på vår hälsa. Stockholm: Statens Folkhälsoinstitut; 2005.11.Jeppsson JO, Kristenson H, Fimi-ani C. Carbohydrate-deficient transferrin quantified by HPLC to determine heavy consumption of alcohol. Clin Chem. 1993;39:2115-20.12.Hasselblatt M, Martin F, Maul O, Ehrenreich H, Kernbach-Wighton G. Persistent macrocytosis following abstinence from chronic alcohol use. J Am Med Assoc. 2001;286:2946.
